Company Filing History:
1 out of 1,744 
1 out of 5,089 
1 out of 132 
Years Active: 2018
Title: Florence Zylbersztejn: Innovator in Cancer Treatment
Introduction
Florence Zylbersztejn is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. Her work focuses on addressing drug-resistant cancers and improving patient outcomes.
Latest Patents
Florence Zylbersztejn holds a patent for a composition that combines a DNA methylation inhibitor and a vitamin D receptor agonist. This invention is aimed at treating drug-resistant cancer and preventing tumor relapse. The patent outlines the use of these two components, either simultaneously or sequentially, to enhance the sensitivity of cancer patients to chemotherapeutic drugs.
Career Highlights
Throughout her career, Zylbersztejn has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Florence has collaborated with notable professionals in her field, including Ivan Cruz-Moura and Olivier Hermine. These partnerships have contributed to her innovative approaches and successful research outcomes.
Conclusion
Florence Zylbersztejn is a trailblazer in the realm of cancer research, with her patented invention offering hope for patients facing drug-resistant cancers. Her dedication to improving treatment options exemplifies the impact of innovation in healthcare.